The Health Sciences Authority (HSA) is moving Singapore medical device submissions to a new e-platform known as the Singapore Health Product Access and Regulatory E-System (SHARE) effective on July 14, 2025. The new system simplifies application procedures and improves user experience throughout the product life cycle.
Under SHARE, applicants will be able to file their Class A product notifications as standalone applications and handle Free Sale Certificate applications on the platform. Third-party access has become easier as well because applicants can now authorize direct access to third parties under SHARE without filing individual identification code requests.
Importers will now become more actively engaged since they need to accept “tagging” assignments on the platform. Assigning wholesalers for device listings is no longer required. In addition, companies can now submit Export Certificate applications without having to first submit a “Notification for Export” document.
SHARE also has more sophisticated application management capabilities, such as dashboards for outstanding actions, status visibility, a list of approved products and licenses, etc.
Submissions via the legacy MEDICS system will no longer be accepted after June 27. Between June 27 and July 14, no new submissions will be accepted. New submissions should be submitted via SHARE from July 14, 2025.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.